E-LIB Suche - Ergebnisse für: Benner, S. E.

1

222 A first-in-human, phase I trial of the anti-DLL4 antibo..:

Smith, D.C. ; Eisenberg, P. ; Stagg, R....
European Journal of Cancer Supplements. 8 (2010) 7 - p. 73 , 2010

2

Randomized Phase III Intergroup Trial of Isotretinoin to Pr..:

Lippman, S. M. ; Lee, J. J. ; Karp, D. D....
JNCI Journal of the National Cancer Institute. 93 (2001) 8 - p. 605-618 , 2001

Link: https://doi.org/10.1093/..

3

BOOK REVIEW:

BENNER, S. E.
JNCI Journal of the National Cancer Institute. 87 (1995) 9 - p. 685-685 , 1995

Link: https://doi.org/10.1093/..

4

Toxicity of Isotretinoin in a Chemoprevention Trial to Prev..:

BENNER, S. E. ; PAJAK, T. F. ; STETZ, J....
JNCI Journal of the National Cancer Institute. 86 (1994) 23 - p. 1799-1801 , 1994

Link: https://doi.org/10.1093/..

5

Prevention of Second Primary Tumors With Isotretinoin in Pa..:

Benner, S. E. ; Pajak, T. F. ; Lippman, S. M...
JNCI Journal of the National Cancer Institute. 86 (1994) 2 - p. 140-141 , 1994

Link: https://doi.org/10.1093/..

6

Chemoprevention of second primary tumours: A model for inte..:

Benner, S.E. ; Lippman, S.M. ; Hong, W.K.
European Journal of Cancer. 30 (1994) 6 - p. 727-729 , 1994

Link: https://doi.org/10.1016/..

7

Retinoids in Chemoprevention of Head and Neck Carcinogenesi:

Lippman, S.M. ; Benner, S.E. ; Hong, W.K.
Preventive Medicine. 22 (1993) 5 - p. 693-700 , 1993

Link: https://doi.org/10.1006/..

8

Clinical Chemoprevention: Developing a Cancer Prevention St..:

Benner, S. E. ; Hong, W. K.
JNCI Journal of the National Cancer Institute. 85 (1993) 18 - p. 1446-1447 , 1993

Link: https://doi.org/10.1093/..

9

Response:

BENNER, S. E. ; WINN, R. J. ; LIPPMAN, S. M..
JNCI Journal of the National Cancer Institute. 85 (1993) 10 - p. 833-833 , 1993

Link: https://doi.org/10.1093/..

10

Regression of Oral Leukoplakia With-Tocopherol: A Community..:

Benner, S. E. ; Winn, R. J. ; Lippman, S. M....
JNCI Journal of the National Cancer Institute. 85 (1993) 1 - p. 44-47 , 1993

Link: https://doi.org/10.1093/..

11

2352 Sunitinib as second-line treatment in patients with ad..:

Neuzillet, C. ; Seitz, J.F. ; Fartoux, L....
European Journal of Cancer. 51 (2015) - p. S452 , 2015

Link: https://doi.org/10.1016/..

12

TRACK-tgHD Minipig – Introduction of a longitudinal tgHD Mi..:

Hölzner, E. ; Baxa, M. ; Nagelmann, N....
Basal Ganglia. 3 (2013) 1 - p. 44 , 2013

Link: https://doi.org/10.1016/..

13

Are hospitals delivering appropriate VTE prevention? The ve..:

Amin, A. ; Spyropoulos, A. C. ; Dobesh, P....
Journal of Thrombosis and Thrombolysis. 29 (2009) 3 - p. 326-339 , 2009

Link: https://doi.org/10.1007/..

14

A novel programme to evaluate and communicate 10-year risk ..:

Benner, J. S. ; Erhardt, L. ; Flammer, M....
International Journal of Clinical Practice. 62 (2008) 10 - p. 1484-1498 , 2008

Link: https://doi.org/10.1111/..

15

PREDICTED RISK IS REDUCED BY AN INTERVENTION PROGRAM TO EVA..:

Erhardt, L. ; Benner, J.S. ; Flammer, M....
Atherosclerosis Supplements. 9 (2008) 1 - p. 11 , 2008

Link: https://doi.org/10.1016/..